Press "Enter" to skip to content

For COVID-19, India’s ‘Feluda’ Better Than Rapid Antigen Test: Scientists

The Feluda take a look at is priced at Rs 500 and might ship a end in 45 minutes. (Representational)

New Delhi:

More correct than a fast antigen take a look at and nearly as fast, India’s CRISPR ‘Feluda’ COVID-19 take a look at that adjustments color on detection of the SARS-CoV-2 virus could possibly be a less expensive, quicker and easier different to an RT-PCR prognosis, say scientists.

Named after Satyajit Ray’s famed detective, the Feluda take a look at, which is priced at Rs 500 and might ship a end in 45 minutes, is ready to differentiate SARS-CoV-2 from different coronaviruses even when genetic variations between them are minute.

The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Feluda take a look at, developed by the New Delhi-based CSIR-Institute of Genomics and Integrative Biology (IGIB) and the TATA Group, acquired regulatory approvals final week from the Drug Controller General of India (DCGI) for industrial launch.

It meets prime quality benchmarks with 96 per cent sensitivity and 98 per cent specificity for detecting the novel coronavirus, Debojyoti Chakraborty, a senior scientist at CSIR-IGIB and a part of the workforce that developed the take a look at, advised PTI.

In any prognosis, sensitivity is outlined as the flexibility of a take a look at to appropriately establish people with the illness, whereas specificity is the flexibility of the assay to precisely establish these with out the illness.

Similar to a being pregnant strip take a look at, Feluda adjustments color if the virus is detected and would not want costly machines for detection.

“The CRISPR technology uses a highly specific CAS9 protein to find and bind to the target COVID signature. This is then coupled with paper-strip chemistry to elicit a visual readout on a paper strip,” Mr Chakraborty defined.

The take a look at may help the nation, with the world’s second highest instances of COVID-19 at 60.74 lakh instances, ramp up testing of the illness rapidly and economically, the researchers behind the take a look at stated in a press release.

Virologist Upasana Ray famous that the CRISPR based mostly COVID-19 detection system is a less expensive choice to RT-PCR assessments, which value over Rs 1,600. The RAT and the Feluda are in the identical worth bracket.

FELUDA, an acronym for the FNCAS9 Editor-Limited Uniform Detection Assay, makes use of an indigenously developed, cutting-edge CRISPR expertise for detection of the genomic sequence of SARS-CoV-2 virus, the scientists stated.

CRISPR is a gene enhancing expertise and is utilized in correcting genetic defects and treating and stopping the unfold of illnesses.

The expertise can detect particular sequences of DNA inside a gene, and makes use of an enzyme functioning as molecular scissors to snip it.

According to Mr Ray, Feluda is able to detecting even low portions of the genetic materials of the novel coronavirus, based mostly on very minute variations of their RNA – the genetic materials of a virus

“Feluda is an alternative to the quantitative RT-PCR tests and is highly specific. It is capable of detecting low copy number nucleic acids (less viral RNA quantity) as well as single nucleotide variations,” Mr Ray, a senior scientist at CSIR-IICB, Kolkata, advised PTI.

She defined that the assessments are so particular that they’ll distinguish SARS-CoV-2 infections from different coronaviruses such because the one which induced the 2002-03 SARS pandemic.

“It can distinguish between SARS-CoV-2 and SARS-CoV sequences which differ by a single nucleotide. Unlike RT-PCR which requires expensive machines, Feluda is simple and can be used in laboratories as well as outside with a quicker turnaround time,” she added.

In May, the US granted emergency-use approval for the world’s first CRISPR-based take a look at for COVID-19, developed by the Massachusetts Institute of Technology (MIT) and Harvard University.

The CRISPR Feluda take a look at is the world’s first diagnostic take a look at to deploy a specifically tailored Cas9 protein, derived from Francisella novicida micro organism, to efficiently detect the virus that causes COVID-19, the researchers stated.

Other CRISPR?assessments, just like the one developed within the US, use CAS12 and CAS13 proteins to detect SARS-CoV-2.

Compared with a fast antigen take a look at, which interprets leads to 30 minutes, Mr Ray stated the Feluda take a look at would take barely longer, as much as 45 minutes, however is extra correct and particular.

Rapid antigen assessments detect the viral proteins or elements thereof whereas CRISPR detects nucleic acids, or RNA in case of COVID-19, Mr Ray stated.

Chakaraborty famous that RT-PCR takes about 1.5 hours, skilled manpower and a devoted and costly RT-PCR machine which isn’t broadly out there.

“Feluda gives similar sensitivity and specificity as RT-PCR but is inexpensive, requires a basic widely available PCR machine and doesn’t require extensive trained manpower. The chemistry and biology is of course different,” Mr Chakraborty added.

“This marks a significant achievement for the Indian scientific community, moving from R&D to a high-accuracy, scalable and reliable test in less than 100 days. The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests, with quicker turnaround time, less expensive equipment, and better ease of use,” the researchers stated of their assertion.

They described CRISPR as a futuristic expertise that will also be configured for detection of different pathogens sooner or later.

“Current R&D is towards making Feluda more point of care, simpler and more deployable to meet the testing needs of the country and enable return to workplaces, schools, etc,” Mr Chakraborty added.

(Except for the headline, this story has not been edited by NDTV employees and is printed from a syndicated feed.)

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: